AI-generated summary
This narrative review examines how skin melanin may affect photobiomodulation therapy outcomes. The authors report that darker skin with higher melanin content may reduce photon penetration, and that most studies and protocols do not account for skin pigmentation. They conclude that tailored protocols are needed, noting that only a few clinical trials have reported outcomes by skin tone.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative review and short communication, which does not systematically count or weigh included studies, and only a few trials reported outcomes by skin tone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Photobiomodulation therapy (PBMT) has been extensively researched for tissue repair, pain relief, and muscle recovery. However, melanin, a primary skin chromophore, can impede photon penetration into darker skin, potentially diminishing the efficacy of PBMT. Despite this, clinical protocols and guidelines seldom account for skin pigmentation when setting parameters, possibly exacerbating racial disparities in healthcare.
Objective
To examine the effect of melanin on the efficacy of PBMT and highlight the necessity for personalized strategies that account for skin pigmentation.
Design And Setting
Short communication conducted at the Universidade de São Paulo (USP), Ribeirão Preto, São Paulo.
Methods
A narrative review of PBMT mechanisms, light-tissue interactions, and the impact of melanin absorption on treatment outcomes was conducted.
Results
The clinical outcomes of PBMT depend on the technical parameters (wavelength, energy, and dose) and skin pigmentation. Darker skin tones with higher melanin content may lead to reduced photon penetration effectiveness. However, most studies and protocols do not consider this variable. Only a few clinical trials have categorized outcomes by skin tone, exposing a notable knowledge gap.
Conclusion
Melanin plays a crucial role in PBMT response, and overlooking skin pigmentation in research and clinical practice could perpetuate disparities. Enhanced and tailored protocols are essential to optimize PBMT outcomes among diverse populations.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Melanin, Photon, Chromophore, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.